NCT02640729View on ClinicalTrials.gov

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Lewy Body DementiaVisual Hallucinations
Interventions
DRUG

Nelotanserin

once daily, oral, 20-mg tablets

DRUG

Placebo

once daily, oral, matching tablets

Trial Locations (10)

27514

US101, Chapel Hill

32806

US113, Orlando

33486

US114, Boca Raton

43210

US105, Columbus

44195

US104, Cleveland

55905

US103, Rochester

66214

US132, Lenexa

68526

US129, Lincoln

78229

US131, San Antonio

92708

US123, Fountain Valley

Sponsors
All Listed Sponsors
lead

Axovant Sciences Ltd.

INDUSTRY